跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOUJEO MAX SOLOSTAR insulin glargine 300 units/mL solution for injection injector pen - TGA Drug Approval Details
Approvals
/
TGA
/
TOUJEO MAX SOLOSTAR insulin glargine 300 units/mL solution for injection injector pen
Approved
STANDARD
TOUJEO MAX SOLOSTAR insulin glargine 300 units/mL solution for injection injector pen
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b0308c126a0854a5
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b0308c126a0854a5
Product Name
TOUJEO MAX SOLOSTAR insulin glargine 300 units/mL solution for injection injector pen
Artg Id
312220
Artg Name
TOUJEO MAX SOLOSTAR insulin glargine 300 units/mL solution for injection injector pen
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2019-11-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4d56c912c8c10950a248a7b8ac3a8eaa.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b0308c126a0854a5
Type
Standard
Back to TGA Approvals